| Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes (NCT00312104) | Novo Nordisk A/S | 2002-04-01 |
| Special Survey of Production of Insulin Aspart Specific Antibody (NCT01487369) | Novo Nordisk A/S | 2002-04-01 |
| Special Survey for Paediatric Subjects (NCT01487382) | Novo Nordisk A/S | 2002-04-01 |
| Special Survey for Type 1 or Type 2 Diabetic Patients (NCT01487408) | Novo Nordisk A/S | 2002-04-01 |
| Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes (NCT01486381) | Novo Nordisk A/S | 2002-03-20 |
| Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes (NCT01465152) | Novo Nordisk A/S | 2002-03-06 |
| Safety and Efficacy of Insulin Aspart in Type 2 Diabetes (NCT01649570) | Novo Nordisk A/S | 2002-03-01 |
| Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes (NCT01486940) | Novo Nordisk A/S | 2002-03-01 |
| Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients (NCT01563523) | Novo Nordisk A/S | 2002-03-01 |
| Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency (NCT00184678) | Novo Nordisk A/S | 2002-02-01 |
| Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes (NCT00676819) | Novo Nordisk A/S | 2002-01-10 |
| Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease (NCT01562574) | Novo Nordisk A/S | 2002-01-01 |
| Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes (NCT01527539) | Novo Nordisk A/S | 2001-11-23 |
| Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes (NCT01605773) | Novo Nordisk A/S | 2001-11-08 |
| Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage (NCT01563445) | Novo Nordisk A/S | 2001-11-01 |
| Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers (NCT01563471) | Novo Nordisk A/S | 2001-10-01 |
| Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers (NCT01511159) | Novo Nordisk A/S | 2001-10-01 |
| Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis (NCT01561352) | Novo Nordisk A/S | 2001-09-01 |
| Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes (NCT01697657) | Novo Nordisk A/S | 2001-09-01 |
| Trial of NovoSeven® in Haemophilia - Joint Bleeds (NCT00108797) | Novo Nordisk A/S | 2001-09-01 |
| Observational Study of NovoNorm® in Subjects With Diabetes (NCT01498913) | Novo Nordisk A/S | 2001-08-30 |
| Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women (NCT01705249) | Novo Nordisk A/S | 2001-08-14 |
| Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures (NCT00254514) | Novo Nordisk A/S | 2001-08-01 |
| Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage (NCT01566786) | Novo Nordisk A/S | 2001-08-01 |
| Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation (NCT01563458) | Novo Nordisk A/S | 2001-08-01 |
| Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy (NCT01562821) | Novo Nordisk A/S | 2001-07-01 |
| Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever (NCT01601613) | Novo Nordisk A/S | 2001-07-01 |
| Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes (NCT01562561) | Novo Nordisk A/S | 2001-06-01 |
| Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes (NCT01508949) | Novo Nordisk A/S | 2001-06-01 |
| Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency (NCT01698944) | Novo Nordisk A/S | 2001-05-16 |
| Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency (NCT01502124) | Novo Nordisk A/S | 2001-05-08 |
| Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes (NCT01526941) | Novo Nordisk A/S | 2001-05-01 |
| Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes (NCT01508923) | Novo Nordisk A/S | 2001-05-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes (NCT01704378) | Novo Nordisk A/S | 2001-04-18 |
| Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes (NCT01509742) | Novo Nordisk A/S | 2001-04-01 |
| Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation (NCT01562158) | Novo Nordisk A/S | 2001-04-01 |
| Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent (NCT01511198) | Novo Nordisk A/S | 2001-02-01 |
| Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group (NCT01511185) | Novo Nordisk A/S | 2001-02-01 |
| Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes. (NCT03220425) | Novo Nordisk A/S | 2001-02-01 |
| Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes (NCT01620424) | Novo Nordisk A/S | 2001-02-01 |
| A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes (NCT00400283) | Novo Nordisk A/S | 2001-01-19 |
| Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01467375) | Novo Nordisk A/S | 2001-01-08 |
| Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes (NCT01524809) | Novo Nordisk A/S | 2001-01-01 |
| Safety and Efficacy of Long-term Somatropin Treatment in Children (NCT01543867) | Novo Nordisk A/S | 2001-01-01 |
| Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes (NCT01650129) | Novo Nordisk A/S | 2000-12-13 |
| Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency (NCT01563926) | Novo Nordisk A/S | 2000-10-23 |
| Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes (NCT01509755) | Novo Nordisk A/S | 2000-10-01 |
| Effect of Growth Hormone in Children With Growth Hormone Deficiency (NCT00262249) | Novo Nordisk A/S | 2000-08-01 |
| Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation (NCT01734447) | Novo Nordisk A/S | 2000-04-30 |
| A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin (NCT00931476) | Novo Nordisk A/S | 2000-04-06 |
| Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes (NCT00065130) | Novo Nordisk A/S | 2000-04-01 |
| Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes (NCT01520818) | Novo Nordisk A/S | 2000-03-01 |
| Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers (NCT01620333) | Novo Nordisk A/S | 2000-02-01 |
| Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes (NCT00832182) | Novo Nordisk A/S | 1999-12-22 |
| Comparison of Two Formulations of Biphasic Insulin Aspart 70 (NCT01523041) | Novo Nordisk A/S | 1999-11-03 |
| A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin (NCT02162407) | Novo Nordisk A/S | 1999-10-01 |
| Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes (NCT01507311) | Novo Nordisk A/S | 1999-09-01 |
| Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes (NCT01507285) | Novo Nordisk A/S | 1999-08-01 |
| Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years (NCT00184691) | Novo Nordisk A/S | 1999-04-01 |
| Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects (NCT01520831) | Novo Nordisk A/S | 1999-04-01 |
| Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice (NCT01579955) | Novo Nordisk A/S | 1999-03-10 |
| Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery (NCT01579968) | Novo Nordisk A/S | 1999-03-10 |
| Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors (NCT01586936) | Novo Nordisk A/S | 1999-03-10 |
| Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes (NCT01520753) | Novo Nordisk A/S | 1999-03-01 |
| Safety and Tolerability of Liraglutide in Healthy Male Volunteers (NCT01507272) | Novo Nordisk A/S | 1999-03-01 |
| Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients (NCT01562834) | Novo Nordisk A/S | 1998-10-21 |
| Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome (NCT01710696) | Novo Nordisk A/S | 1998-07-23 |
| Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery (NCT01561391) | Novo Nordisk A/S | 1998-04-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes (NCT01467323) | Novo Nordisk A/S | 1998-04-01 |
| Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. (NCT00184769) | Novo Nordisk A/S | 1998-01-29 |
| Comparison of 2 NovoFine® Needles on the Reflux of Insulin (NCT00872560) | Novo Nordisk A/S | 1998-01-20 |
| Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes (NCT01707134) | Novo Nordisk A/S | 1997-09-01 |
| Special Survey for Long Term Application (NCT01516229) | Novo Nordisk A/S | 1997-05-01 |
| Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles (NCT00871416) | Novo Nordisk A/S | 1997-04-09 |
| Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01697618) | Novo Nordisk A/S | 1997-04-01 |
| Growth Response in Girls With Turner Syndrome (NCT01734486) | Novo Nordisk A/S | 1996-09-23 |
| Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers (NCT01707160) | Novo Nordisk A/S | 1995-11-01 |
| Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial (NCT00464971) | Novo Nordisk A/S | 1995-01-31 |
| Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis (NCT00465192) | Novo Nordisk A/S | 1994-08-31 |
| Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation (NCT01697644) | Novo Nordisk A/S | 1990-10-01 |
| Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome (NCT01529840) | Novo Nordisk A/S | 1990-06-01 |
| Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin (NCT00410033) | Novo Nordisk A/S | 1989-12-01 |
| Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome (NCT01518062) | Novo Nordisk A/S | 1989-11-01 |
| Use of Somatropin in Turner Syndrome (NCT01518036) | Novo Nordisk A/S | 1987-09-14 |
| Compassionate Use of Concizumab if You Have Haemophilia (NCT04921956) | Novo Nordisk A/S | |